Latest News
Charter NEX Films, a producer of high-polyethylene films, is pleased to announce that it has completed the acquisition of Optimum Plastics, in an all-cash transaction for an undisclosed amount.
Charter NEX supplies flexible packaging converters with a broad array of products, from monolayer to high barrier films, for the retail food, consumer products, industrial, and medical markets. Charter NEX is well-regarded for its best-in-class quality standards and manufacturing performance. The company is owned by Pamplona Capital Management, LLP (“Pamplona”), a global private equity investment firm, and management.
“We are excited to be joining forces with Optimum Plastics,” says Kathy
Investors remain bullish about private equity with average annual return expectations – net of fees, expenses and carried interest – of 11.7 per cent IRR and 1.6x multiple of cost (MoC) for managers that begin investing today.
That’s according to a survey by fundraising and secondaries advisory firm Rede, which reveal that for top-quartile managers this increases to a net IRR of 17.4 per cent and 2.0x net MoC.
The survey included responses from a broad range of investors (pension funds, fund of funds, endowments and consultants) based in Europe, North America and the rest of the world.
Edesix, a UK-based provider of body worn camera (BWC) solutions, has secured further investment from Panoramic Growth Equity, who have been backing the company since 2014.
Edesix has raised a further GBP750,000 to fund expansion into new markets and to continue the development of its technology, product range and sales infrastructure both in the UK and overseas.
Headquartered in Edinburgh, UK and established in 2002, Edesix manufactures BWC’s for those in public facing roles, helping to improve safety, while producing compelling legal evidence when needed. Edesix currently provides VideoBadges and VideoManager footage management software to local authority enforcement teams,
The John Laing Environmental Asset Group (JLEN) has acquired Burton Wold Extension wind farm from John Laing Group (John Laing) for a cash consideration, including working capital, of GBP21.8 million.
Burton Wold Extension wind farm is located near Burton Latimer in Northamptonshire and comprises nine General Electric 1.6MW-100 turbines with a total generating capacity of 14.4MW and is accredited for 0.9 ROCs. The site has been operational since September 2014.
This acquisition, which was agreed in accordance with the First Offer Agreement between John Laing and JLEN, brings the total capacity of the renewable energy assets in the JLEN
GHO Capital, the European specialist healthcare investor, today announces the acquisition of Quotient Clinical (Quotient or the Company), a provider of outsourced, early-stage drug development services to the pharmaceutical industry.
Headquartered in the UK and employing over 280 professionals, Quotient Clinical enables pharmaceutical and biotechnology customers to improve research and development productivity and accelerate drug development timelines.
Quotient Clinical’s Translational Pharmaceutics® platform offers a differentiated service proposition in the form of an integrated approach to drug formulation development, “real-time” manufacturing and clinical testing within a single location. With significant time and cost savings, customers are able to bring drug
Assets under administration at private equity fund administrator Gen II Fund Services now exceed USD100 billion.
Since its founding in 2009, Gen II has grown significantly to become the industry's largest independent firm focused on private equity fund administration.
Norman Leben, Managing Principal of Gen II says: "Achieving this level of assets under administration as quickly as we have is an extraordinary milestone for Gen II. We have continued to attract premier clients, which we believe is the result of our unmatched level of expertise. Our work with complex fund structures, complemented by our ability to execute at the
The investment bank Arjil – Groupe Altium has advised JRI’s shareholders for the sale of the company to Turenne Santé, Bpifrance and InnovaFonds as part of an LMBI.
JRI is the French leading specialist in the design and distribution of wireless monitoring solutions and chart recorders for controlling and monitoring physical quantities such as temperature, relative humidity, pressure, water consumption and electricity consumption. JRI’s products and solutions are targeted to professional clients, mainly in the life sciences, food and beverage and industrial sectors.
JRI generated approximately 12 million euros in turnover during the year 2014.
JRI was owned since
Livingstone has advised the shareholders of Tessella, including Mobeus Equity Partners, on its sale to Altran, a provider of innovation and high-tech engineering services.
Tessella is an international analytics, software and consulting services organisation and its proven capability in data analytics will enhance Altran’s Intelligent Systems division and VueForge offer.
Headquartered in Abingdon near Oxford, Tessella is known for finding and delivering innovative answers to the complex business and technical challenges of some of the world’s most forward-thinking organisations in the aerospace and defence, consumer goods, energy, life sciences, and science research sectors.
Established in 1980, Tessella has
Endpoint security software firm, Avecto, has received a USD49 million (GBP32 million) minority investment from JMI Equity, a growth equity firm focused on investing in leading software and services companies.
As part of the transaction, Jit Sinha, General Partner, and Suken Vakil, Principal, at JMI Equity will join the Board of Directors.
Avecto is a market leader in the large and fast-growing $3 billion endpoint security sector. Headquartered in Manchester, UK, with offices in Boston, USA, Melbourne, Australia and Frankfurt, Germany, Avecto was founded by entrepreneurs Mark Austin and Paul Kenyon in 2008. Since that time, the company has
Renaissance Capital has completed the sale of Deutsche Investitions- und Entwicklungsgesellschaft’s (DEG) remaining holding in TBC Bank, a leading universal bank in Georgia.
DEG was one of TBC Bank’s four International Financial Institution (IFI) shareholders holding 3.6% of the Bank. DEG’s shares were acquired by a number of institutional investors from the UK and Continental Europe.
The placement of the TBC Bank shares is the sixth equity transaction in Georgia since 2013 completed by Renaissance Capital.
John Porter, Head of Financing Group, Renaissance Capital, says: “We are pleased to work on yet another equity transaction in Georgia, which
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
